RSM and McGuire Woods present the 15th annual health care and life sciences private equity conference for deal professionals.
This recent interview with Risk & Compliance magazine discusses the unique bribery and corruption risks life sciences organizations face.
Learn what the board and others who have executive oversight of life sciences companies need to understand about minimizing corruption risk.
This case study focuses on the importance of a deep understanding in life sciences company valuations. Learn more.
With IPO on the line, RSM delivers valuation client needs to finance the future.